Jan 12 (Reuters) - Health insurer UnitedHealth Group ​used aggressive ‌tactics to gather diagnoses that ‌can boost Medicare Advantage payments, the Wall Street Journal ⁠reported on ‌Monday, citing a U.S. Senate ‍committee investigating the company's practices. Shares of the company ​were down 1.7% ‌to $339.42 in early trading on Monday. The Senate report makes no formal recommendations and does ⁠not accuse UnitedHealth ​of wrongdoing, ​the Journal reported. The company did not ‍immediately ⁠respond to a Reuters request for ⁠comment. Sign up for the Yahoo Finance Morning Brief By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy Subscribe(Reporting by Sneha S ‌K; Editing by ‌Tasim Zahid)

Source: Wall Street Journal January 12, 2026 13:36 UTC